Benefits and challenges of ultra-fast, short-acting psychedelics in the treatment of depression / Johannes G. Ramaekers en The American Journal of Psychiatry, Año 2025 - Vol. 182 - No.1 (Enero)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 33-46 Título : Benefits and challenges of ultra-fast, short-acting psychedelics in the treatment of depression Tipo de documento: texto impreso Autores: Johannes G. Ramaekers, Autor ; Johannes T. Reckweg, Autor ; Natasha L. Mason, Autor Fecha de publicación: 2025 Artículo en la página: pp. 33-46 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: 5-MeO-DMT, DMT, Depresión, Psicodélicos. Resumen: Unlike classical antidepressants, psychedelics such as psilocybin have been shown to induce a rapid antidepressant response. In the wake of this development, interest has emerged in ultra-fast, short-acting psychedelics such as 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and N,N-dimethyltryptamine (DMT) with the expectation that these can produce rapid antidepressant effects following an intense but brief psychedelic intervention. Link: ./index.php?lvl=notice_display&id=31557 [artículo] Benefits and challenges of ultra-fast, short-acting psychedelics in the treatment of depression [texto impreso] / Johannes G. Ramaekers, Autor ; Johannes T. Reckweg, Autor ; Natasha L. Mason, Autor . - 2025 . - pp. 33-46. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 33-46 Palabras clave: 5-MeO-DMT, DMT, Depresión, Psicodélicos. Resumen: Unlike classical antidepressants, psychedelics such as psilocybin have been shown to induce a rapid antidepressant response. In the wake of this development, interest has emerged in ultra-fast, short-acting psychedelics such as 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and N,N-dimethyltryptamine (DMT) with the expectation that these can produce rapid antidepressant effects following an intense but brief psychedelic intervention. Link: ./index.php?lvl=notice_display&id=31557

Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity / Natasha L. Mason en European Neuropsychopharmacology, Año 2019 - Vol. 29 - No. 2 (Febrero)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2019 - Vol. 29 - No. 2 (Febrero) . - pp. 247-256 Título : Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity Tipo de documento: texto impreso Autores: Natasha L. Mason, Autor ; Eef Lien Theunissen, Autor ; Nadia R.P.W. Hutten, Autor Fecha de publicación: 2021 Artículo en la página: pp. 247-256 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: THC, Canabis, Espectroscopia de resonancia magnética de protones, Conectividad funcional, Glutamato, Dopamina Resumen: Cannabis is the most commonly used illicit drug and is known to alter state of consciousness and impair neurocognitive function. However, the mechanisms underlying these effects have yet to be fully elucidated. Link: ./index.php?lvl=notice_display&id=26366 [artículo] Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity [texto impreso] / Natasha L. Mason, Autor ; Eef Lien Theunissen, Autor ; Nadia R.P.W. Hutten, Autor . - 2021 . - pp. 247-256. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2019 - Vol. 29 - No. 2 (Febrero) . - pp. 247-256 Palabras clave: THC, Canabis, Espectroscopia de resonancia magnética de protones, Conectividad funcional, Glutamato, Dopamina Resumen: Cannabis is the most commonly used illicit drug and is known to alter state of consciousness and impair neurocognitive function. However, the mechanisms underlying these effects have yet to be fully elucidated. Link: ./index.php?lvl=notice_display&id=26366

---

1 (1 - 2 / 2)